Inclusion of Flagellin during Vaccination against Influenza Enhances Recall Responses in Nonhuman Primate Neonates

ABSTRACT Influenza virus can cause life-threatening infections in neonates and young infants. Although vaccination is a major countermeasure against influenza, current vaccines are not approved for use in infants less than 6 months of age, in part due to the weak immune response following vaccination. Thus, there is a strong need to develop new vaccines with improved efficacy for this vulnerable population. To address this issue, we established a neonatal African green monkey (AGM) nonhuman primate model that could be used to identify effective influenza vaccine approaches for use in young infants. We assessed the ability of flagellin, a Toll-like receptor 5 (TLR5) agonist, to serve as an effective adjuvant in this at-risk population. Four- to 6-day-old AGMs were primed and boosted with inactivated PR8 influenza virus (IPR8) adjuvanted with either wild-type flagellin or inactive flagellin with a mutation at position 229 (m229), the latter of which is incapable of signaling through TLR5. Increased IgG responses were observed following a boost, as well as at early times after challenge, in infants vaccinated with flagellin-adjuvanted IPR8. Inclusion of flagellin during vaccination also resulted in a significantly increased number of influenza virus-specific T cells following challenge compared to the number in infants vaccinated with the m229 adjuvant. Finally, following challenge infants vaccinated with IPR8 plus flagellin exhibited a reduced pathology in the lungs compared to that in infants that received IPR8 plus m229. This study provides the first evidence of flagellin-mediated enhancement of vaccine responses in nonhuman primate neonates. IMPORTANCE Young infants are particularly susceptible to severe disease as a result of influenza virus infection. Compounding this is the lack of effective vaccines for use in this vulnerable population. Here we describe a vaccine approach that results in improved immune responses and protection in young infants. Incorporation of flagellin during vaccination resulted in increased antibody and T cell responses together with reduced disease following virus infection. These results suggest that flagellin may serve as an effective adjuvant for vaccines targeted to this vulnerable population.

[1]  V. Bhandari,et al.  The Human Neonatal Gut Microbiome: A Brief Review , 2015, Front. Pediatr..

[2]  G. Parks,et al.  Nonhuman primate infants have an impaired respiratory but not systemic IgG antibody response following influenza virus infection. , 2015, Virology.

[3]  Helder I Nakaya,et al.  TLR5-mediated sensing of gut microbiota is necessary for antibody responses to seasonal influenza vaccination. , 2014, Immunity.

[4]  S. Bertholet,et al.  Unleashing the potential of NOD- and Toll-like agonists as vaccine adjuvants , 2014, Proceedings of the National Academy of Sciences.

[5]  K. Kalanetra,et al.  Stool Microbiota and Vaccine Responses of Infants , 2014, Pediatrics.

[6]  B. Graham,et al.  Quantitative and Qualitative Deficits in Neonatal Lung-Migratory Dendritic Cells Impact the Generation of the CD8+ T Cell Response , 2014, PLoS pathogens.

[7]  D. Lowy,et al.  Comparison of Antibody Responses to Human Papillomavirus Vaccination as Measured by Three Assays , 2014, Front. Oncol..

[8]  Shirin Tarahomjoo.  Utilizing bacterial flagellins against infectious diseases and cancers , 2013, Antonie van Leeuwenhoek.

[9]  S. Reed,et al.  Key roles of adjuvants in modern vaccines , 2013, Nature Medicine.

[10]  J. Kelton,et al.  The effect of rituximab on vaccine responses in patients with immune thrombocytopenia. , 2013, Blood.

[11]  O. Leo,et al.  Neonatal Follicular Th Cell Responses Are Impaired and Modulated by IL-4 , 2013, The Journal of Immunology.

[12]  P. Ghazal,et al.  Early life response to infection , 2013, Current opinion in infectious diseases.

[13]  D. Lewis,et al.  Human Neonatal Naive CD4+ T Cells Have Enhanced Activation-Dependent Signaling Regulated by the MicroRNA miR-181a , 2013, The Journal of Immunology.

[14]  L. Moldawer,et al.  Role of Innate Immunity in Neonatal Infection , 2013, American Journal of Perinatology.

[15]  A. Klimov,et al.  Influenza virus titration, antigenic characterization, and serological methods for antibody detection. , 2012, Methods in molecular biology.

[16]  Kathy Hancock.  Influenza A Virus , 2020, Definitions.

[17]  P. Dash,et al.  Neonatal CD8 T-cell Hierarchy Is Distinct from Adults and Is Influenced by Intrinsic T cell Properties in Respiratory Syncytial Virus Infected Mice , 2011, PLoS pathogens.

[18]  David N. Taylor,et al.  Safety and immunogenicity of a recombinant M2e-flagellin influenza vaccine (STF2.4xM2e) in healthy adults. , 2011, Vaccine.

[19]  J. Treanor,et al.  Induction of a potent immune response in the elderly using the TLR-5 agonist, flagellin, with a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125, STF2.HA1 SI). , 2011, Vaccine.

[20]  C. Bode,et al.  TLR-based immune adjuvants. , 2011, Vaccine.

[21]  John Steel,et al.  Programming the magnitude and persistence of antibody responses with innate immunity , 2010, Nature.

[22]  hristine B. Turleya,et al.  afety and immunogenicity of a recombinant M 2 e – flagellin influenza vaccine STF 2 . 4 xM 2 e ) in healthy adults , 2011 .

[23]  Uma Kavita,et al.  Immunopotentiation of Trivalent Influenza Vaccine When Given with VAX102, a Recombinant Influenza M2e Vaccine Fused to the TLR5 Ligand Flagellin , 2010, PloS one.

[24]  J. Treanor,et al.  Safety and immunogenicity of a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125) in healthy young adults. , 2010, Vaccine.

[25]  J. Bates,et al.  Flagellin as an Adjuvant: Cellular Mechanisms and Potential , 2010, The Journal of Immunology.

[26]  Samantha N. Hoskins,et al.  The Migration of T Cells in Response to Influenza Virus Is Altered in Neonatal Mice , 2010, The Journal of Immunology.

[27]  Zhiyong Guo,et al.  “Default” Generation of Neonatal Regulatory T Cells , 2010, The Journal of Immunology.

[28]  Bali Pulendran,et al.  Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus , 2010, Proceedings of the National Academy of Sciences.

[29]  R. Compans,et al.  Salmonella flagellins are potent adjuvants for intranasally administered whole inactivated influenza vaccine. , 2010, Vaccine.

[30]  M. Tinguely,et al.  Plasma cell toll‐like receptor (TLR) expression differs from that of B cells, and plasma cell TLR triggering enhances immunoglobulin production , 2009, Immunology.

[31]  Christine M. Hoeman,et al.  Neonatal immunity: faulty T-helpers and the shortcomings of dendritic cells. , 2009, Trends in immunology.

[32]  S. Mizel,et al.  Immunization of young African green monkeys with OprF epitope 8-OprI-type A- and B-flagellin fusion proteins promotes the production of protective antibodies against nonmucoid Pseudomonas aeruginosa. , 2009, Vaccine.

[33]  Matthew Thompson,et al.  Neuraminidase inhibitors for treatment and prophylaxis of influenza in children: systematic review and meta-analysis of randomised controlled trials , 2009, BMJ : British Medical Journal.

[34]  J. Brenchley,et al.  Down-regulation of CD4 by memory CD4+ T cells in vivo renders African green monkeys resistant to progressive SIVagm infection , 2009, Nature Medicine.

[35]  J. Marvel,et al.  TLR2 Engagement on CD8 T Cells Enables Generation of Functional Memory Cells in Response to a Suboptimal TCR Signal1 , 2009, The Journal of Immunology.

[36]  D. Reen,et al.  Activated Human Neonatal CD8+ T Cells Are Subject to Immunomodulation by Direct TLR2 or TLR5 Stimulation1 , 2009, The Journal of Immunology.

[37]  M. Suter,et al.  Phenotype and function of neonatal DC , 2009, European journal of immunology.

[38]  O. Levy,et al.  Safety and efficacy of neonatal vaccination , 2009, European journal of immunology.

[39]  S. Mizel,et al.  Flagellin-F1-V Fusion Protein Is an Effective Plague Vaccine in Mice and Two Species of Nonhuman Primates , 2008, Clinical and Vaccine Immunology.

[40]  J. Ellis,et al.  Delayed maturation of an IL-12–producing dendritic cell subset explains the early Th2 bias in neonatal immunity , 2008, The Journal of experimental medicine.

[41]  K. Ruxrungtham,et al.  Expression and function of Toll-like receptors on dendritic cells and other antigen presenting cells from non-human primates. , 2008, Veterinary immunology and immunopathology.

[42]  Qingxia Chen,et al.  Safety and immunogenicity of trivalent inactivated influenza vaccine in infants. , 2008, The Journal of infectious diseases.

[43]  J. Bates,et al.  Mucosal adjuvant activity of flagellin in aged mice , 2008, Mechanisms of Ageing and Development.

[44]  T. McGaha,et al.  APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells. , 2008, Blood.

[45]  S. Alexander,et al.  T Regulatory Cells Contribute to the Attenuated Primary CD8+ and CD4+ T Cell Responses to Herpes Simplex Virus Type 2 in Neonatal Mice1 , 2008, The Journal of Immunology.

[46]  R. K. Evans,et al.  Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin. , 2008, Vaccine.

[47]  F. Carbone,et al.  Neonatal CD8+ T cells are slow to develop into lytic effectors after HSV infection in vivo , 2008, European journal of immunology.

[48]  S. Alexander,et al.  T Regulatory Cells Contribute to the Attenuated Primary CD8 and CD4 T Cell Responses to Herpes Simplex Virus Type 2 in Neonatal Mice , 2008 .

[49]  N. Greenspan,et al.  Decreased expression of tumor necrosis factor family receptors involved in humoral immune responses in preterm neonates. , 2007, Blood.

[50]  F. Zepp,et al.  Combined Toll-like receptor agonists synergistically increase production of inflammatory cytokines in human neonatal dendritic cells. , 2007, Human immunology.

[51]  B. Pulendran,et al.  Toll-Like Receptor Expression and Responsiveness of Distinct Murine Splenic and Mucosal B-Cell Subsets , 2007, PloS one.

[52]  W. Walker,et al.  Neonatal B Cells Suppress Innate Toll-Like Receptor Immune Responses and Modulate Alloimmunity1 , 2007, The Journal of Immunology.

[53]  C. Siegrist.  The challenges of vaccine responses in early life: selected examples. , 2007, Journal of comparative pathology.

[54]  R. Kornbluth,et al.  Immunostimulatory combinations: designing the next generation of vaccine adjuvants , 2006, Journal of leukocyte biology.

[55]  Edgar Schmitt,et al.  Synergistic activation of dendritic cells by combined Toll-like receptor ligation induces superior CTL responses in vivo. , 2006, Blood.

[56]  S. Akira,et al.  TLR2 engagement on CD8 T cells lowers the thresholdfor optimal antigen‐induced T cell activation , 2006, European journal of immunology.

[57]  S. Mizel,et al.  Flagellin Is an Effective Adjuvant for Immunization against Lethal Respiratory Challenge with Yersinia pestis , 2006, Infection and Immunity.

[58]  D. Lewis,et al.  Impaired allogeneic activation and T-helper 1 differentiation of human cord blood naive CD4 T cells. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[59]  P. Doherty,et al.  Cell-mediated Protection in Influenza Infection , 2006, Emerging infectious diseases.

[60]  M. Levings,et al.  Human CD4+ T Cells Express TLR5 and Its Ligand Flagellin Enhances the Suppressive Capacity and Expression of FOXP3 in CD4+CD25+ T Regulatory Cells1 , 2005, The Journal of Immunology.

[61]  K. Takeda.  [Toll-like receptor]. , 2005, Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology.

[62]  H. Gascan,et al.  Direct Stimulation of Human T Cells via TLR5 and TLR7/8: Flagellin and R-848 Up-Regulate Proliferation and IFN-γ Production by Memory CD4+ T Cells1 , 2005, The Journal of Immunology.

[63]  Cheryl A. Jones,et al.  HSV induces an early primary Th1 CD4 T cell response in neonatal mice, but reduced CTL activity at the time of the peak adult response , 2005, European journal of immunology.

[64]  Cheng-ming Sun,et al.  Upon TLR9 signaling, CD5+ B cells control the IL-12-dependent Th1-priming capacity of neonatal DCs. , 2005, Immunity.

[65]  S. Mizel,et al.  Mucosal Administration of Flagellin Induces Innate Immunity in the Mouse Lung , 2004, Infection and Immunity.

[66]  C. Leclerc,et al.  Neonatal adaptive immunity comes of age , 2004, Nature Reviews Immunology.

[67]  J. Ellis,et al.  IL-4 utilizes an alternative receptor to drive apoptosis of Th1 cells and skews neonatal immunity toward Th2. , 2004, Immunity.

[68]  L. West,et al.  Species comparison of anatomical and functional immune system development. , 2003, Birth defects research. Part B, Developmental and reproductive toxicology.

[69]  S. Akira,et al.  Toll‐like receptor expression in murine DC subsets: lack of TLR7 expression by CD8α+ DC correlates with unresponsiveness to imidazoquinolines , 2003, European journal of immunology.

[70]  P. Lambert,et al.  Unresponsiveness to Lymphoid-Mediated Signals at the Neonatal Follicular Dendritic Cell Precursor Level Contributes to Delayed Germinal Center Induction and Limitations of Neonatal Antibody Responses to T-Dependent Antigens 1 , 2003, The Journal of Immunology.

[71]  A. Aderem,et al.  The Toll-Like Receptor 5 Stimulus Bacterial Flagellin Induces Maturation and Chemokine Production in Human Dendritic Cells , 2003 .

[72]  W. Dupont,et al.  Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: the pediatric experience , 2001, The Pediatric infectious disease journal.

[73]  Patrick F. McDermott,et al.  High-Affinity Interaction between Gram-Negative Flagellin and a Cell Surface Polypeptide Results in Human Monocyte Activation , 2000, Infection and Immunity.

[74]  L. Ferreira,et al.  Salmonella flagellin fused with a linear epitope of colonization factor antigen I (CFA/I) can prime antibody responses against homologous and heterologous fimbriae of enterotoxigenic Escherichia coli. , 2000, Research in microbiology.

[75]  M. Vitale,et al.  Inefficient phospholipase C activation and reduced Lck expression characterize the signaling defect of umbilical cord T lymphocytes. , 1999, Journal of immunology.

[76]  H. Bada,et al.  Interleukin-6, C-Reactive Protein, and Abnormal Cardiorespiratory Responses to Immunization in Premature Infants , 1998, Pediatrics.

[77]  M. Pagano,et al.  Hunger in Children in the United States: Potential Behavioral and Emotional Correlates , 1998, Pediatrics.

[78]  W. P. Glezen,et al.  Influenza virus infections in infants. , 1997, The Pediatric infectious disease journal.

[79]  Y. Murayama,et al.  CD4 and CD8 expressions in African green monkey helper T lymphocytes: implication for resistance to SIV infection. , 1997, International immunology.

[80]  H. Ochs,et al.  Diminished expression of CD40 ligand by activated neonatal T cells. , 1995, The Journal of clinical investigation.

[81]  D. Deluca,et al.  Phenotypic and functional immaturity of human umbilical cord blood T lymphocytes. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[82]  M. Levin,et al.  Immunization of high-risk infants younger than 18 months of age with split-product influenza vaccine. , 1991, Pediatrics.

[83]  A. Hislop,et al.  Morphometric studies on the structural development of the lung in Macaca fascicularis during fetal and postnatal life. , 1984, Journal of anatomy.